Bulk ingredients

(Image: iStock/Sky_Blue)

WuXi AppTec subsidiary passes third US FDA inspection

By Melissa Fassbender

WuXi AppTec has announced that its Jinshan Shanghai-based small molecule active pharmaceutical ingredient (API) and advanced intermediate manufacturing facility has passed its third US FDA inspection.

(Image: iStock)

CRO Velesco Pharma adds compound management services

By Melissa Fassbender

The contract research organization (CRO) Velesco Pharma has opened a new laboratory in its Plymouth, MI-based facility to support an increased demand for materials management.

iStock\Gajus

Cambrex predicts flat generic API sales for 2016

Cambrex to start work on Pharma 4 API site in 2016

By Gareth Macdonald

Cambrex has said it will invest around $20m in its Pharma 4 API facility before the end of the year in an effort to get ahead of the capacity utilisation curve.

iStock/theojohns

Patheon will list on NYSE today

By Gareth Macdonald

API and drug maker Patheon will begin trading on the New York Stock Exchange under the symbol PTHN later today.

FDA adds 4 API manufacturers to 'Red List'

FDA adds 4 API manufacturers to 'Red List'

By Melissa Fassbender

Two Chinese and two Indian companies have been banned from importing APIs to the US – one manufacturer says it’s making GMP compliance a “priority.”